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The complexity and cost of cardiovascular medical care 
dictate research to deliver high quality and cost-conscious 
cardiovascular care. This goal is aided by modeling medical 
decision making. To be useful, the modeling must be based 
on real data so that the results can serve as a guide to actual 
practice. It is suggested that a registry of randomized clinical 
trials and larger data bases in cardiovascular disease and 
health care delivery be established. The registry would be a 
In recent years, there has been increased efficacy in health 
care, especially in the areas of diagnosis and therapeutics, as 
opposed to preventive medicine. In large part, the progress 
represents both high technology and new drugs that are the 
outgrowth of expensive drug development programs. This 
progress, with the associated costs, has increased the need 
for efficient and effective methods of diagnosis and treatment 
of disease. The appropriate clinical procedures need to be 
constantly updated in this rapidly changing environment. 
Limited societal resources dictate an increased emphasis on 
critically modeling and evaluating components of the health 
care delivery system. Methods to facilitate appropriate eval- 
uation are desirable. Especially appropriate data come from 
comparative trials of diagnostic and therapeutic procedures 
and from large comprehensive data bases. In the past, the 
usual source of data for modeling has been published scien- 
tific studies. At the current time, because of rapid techno- 
logic change, the computerization of data and the increased 
need for complex multivariate analyses, approaches other 
than published studies may better help society more effi- 
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resource for those desiring to model decision making. The 
registry would contain key words allowing retrieval by 
modelers accessing the registry and would contain contact 
information for consideration of possible collaborative work. 
The initiation of such a registry should contain plans for its 
evaluation to determine whether the registry itself is a 
cost-effective tool to encourage the needed research. 
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ciently use finite resources. Examples of areas of cardio- 
vascular care with inadequate research support include 
electrophysiologic testing, the use of antiarrhythmic drugs, 
percutaneous transluminal coronary angioplasty, coronary 
bypass surgery, percutaneous balloon valvuloplasty and 
percutaneous angioscopy. Fostering research collaboration 
between decision modelers and other researchers with ap- 
propriate data may provide a sound empiric foundation for 
discussion of policy issues. 
Appropriateness of Research Collaboration 
Societal needs in our complex, technologic medical care 
delivery system suggest that important data should be used 
for multiple purposes; this position report considers the 
sharing of collected data (with or without the involvement of 
those collecting the data) where the data are used for other 
purposes. In the following discussion, we shall restrict 
ourselves to consideration of data collected by one group, 
although the one group may consist of many units (for 
example, clinics in a collaborative study). There is special 
interest in using data for modeling to suggest cost-effective 
health care algorithms. 
There are reasons why such research collaboration may 
be beneficial, as well as reasons why it may not be beneficial. 
The following list is not exhaustive and often the points 
overlap. 
Reasons that research collaboration would be beneficial. 
These include the following: 
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There is a potential large societal benefit in developing 
efficacious and cost-effective health care delivery. 
Because of the high cost of medical research and of 
collecting extensive quality data banks, maximal benefit 
should be accrued from data collected. 
Individuals who design a study and collect the data 
benefit by publication and productive collaboration when 
these data are used for other purposes. 
“Good will” can be generated when data collected for 
one purpose are also used for another worthwhile pur- 
pose; for example, drug trials conducted by pharmaceu- 
tical companies may contain data that could be used in 
modeling potential therapeutic strategies. 
By contrasting data collected in different situations and 
different clinics, information may result about variability 
in results among different settings and populations, and 
models developed would be more generalizable. (A word 
of caution: such efforts are perilous because of different 
data collected, different meanings of the “same” data and 
other pitfalls of lack of standardization.) 
Data collected at many sites as new techniques are 
introduced allow evaluation of a possible learning curve 
(especially in procedural areas). Questions such as “is a 
high volume needed to maintain a good outcome?” re- 
quire data from many clinics for an answer. Collaborative 
data would permit such questions to be addressed. 
Researchers may be able to work on a problem for which 
they have a strong interest, but little opportunity. 
It may be possible to use a registry to identify unpub- 
lished negative results. 
Disadvantages of research collaboration. At the same 
time, it must be recognized that there are legitimate reasons 
that argue against such research collaboration. Some rea- 
sons are: 
2) 
To maintain high quality research, it is necessary to 
motivate talented individuals; there are many reasons 
(almost invariably mixed reasons) for any individual to 
dedicate his or her life to research. Individuals perform 
research because of intellectual curiosity about the out- 
come, an altruistic desire to solve a specific problem, a 
need to establish a scientific reputation through publica- 
tion of results and because it is expected of them. Those 
who have put in the time and effort to collect data have a 
right to “mine” the data; as it is said, “the laborer is 
worthy of his hire.” Phrased another way, researchers 
who have invested considerable effort to collect the data 
may not want to subsidize others. 
When individuals who did not collect data obtain the data 
for analysis, they are much more likely to make mistakes 
in assumptions and to perform inappropriate analyses. 
Individuals who collect data get a feeling about which 
data are reliable and which data points are not, whether 
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there have been systematic changes over time and other 
related issues. Thus, the possibility of inappropriate 
analysis is increased when the data are used by other 
researchers. 
Research collaboration of this type distracts the research- 
ers collecting the data from the main tasks at hand. 
Anyone who has given out complex data files on com- 
puter tapes to others knows that there is no way to avoid 
a variety of inquiries and some service to the users. Even 
if collected data were put into a registry that contained 
the data along with appropriate information and instruc- 
tions, it would take considerable time to prepare this in an 
appropriate form. 
Data relating to important medical care procedures, drugs 
or diagnostic tests are sometimes desired by individuals 
who are poor scientists. Some individuals would be 
delighted to obtain the data collected by others and 
subject it to very biased presentation either to justify their 
particular point of view or to attack and discredit findings 
they do not like. 
The motivation for collecting data may be proprietary. 
For example, a pharmaceutical firm investigates a new 
drug with the hope of marketing that drug, recouping 
development costs and making a profit. The company 
may wish to delay as long as possible public knowledge 
about development of the drug for a variety of reasons, 
including the wish to slow the development and market- 
ing of related chemical compounds by others. 
When data sets are presented in their entirety, there is 
potential exposure of the morbidity and mortality of 
various therapies and procedures for individual clinics 
and individual treating physicians. This could have long- 
term implications for willingness to participate in collab- 
orative research. 
There may be an adequate ongoing data base collected for 
other purposes than research; for example, procedures at 
a clinic may be registered for billing purposes or follow- 
up investigations may be done to help evaluate the 
clinical programs. Collaborative research would undoubt- 
edly involve personnel and very possibly computer time 
for which there is no adequate financial support. 
The appropriate weights for the advantages and disadvan- ^ . 
tages of a data registry are not clear; resolution involves 
value judgments. There are both pluses and minuses to any 
strategy designed to enhance collaborative research for 
decision modeling of cardiovascular data. 
Possible Methods of Facilitating 
Research Collaboration 
Some possible models to facilitate research collaboration 
are discussed with a few comments about possible benefits 
and drawbacks. 
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1) Published studies. Use of these is the classic method, 
and there are many pluses to this approach. Published study 
results maintain priority for those collecting and analyzing 
the data. The investigators can publish the most reliable part 
of their data, with appropriate caveats and qualifications; the 
work is then in the public domain and available for others to 
criticize and discuss. There are also important limitations. 
Often there is a time lag between completion of a project and 
publication. In addition, publication studies rarely have 
enough multivariate information to allow appropriate deci- 
sion modeling. 
2) A registry of descriptions of ongoing and completed 
studies and data bases without the actual data. This would be 
a registry of studies, not the studies themselves. The registry 
would record the fact that the study exists with some 
indication of the design, the data collected and the data 
available for collaborative use, and an individual or mailing 
address for further information would be provided. Such a 
registry could bring people together in a timely fashion and 
facilitate rapid and appropriate analysis. However, a variety 
of issues would need to be resolved. What criteria should be 
used for enrolling studies and data bases in the registry? 
Should it be restricted to studies involving at least a certain 
number of individuals or at least a certain amount of data? 
Should it be restricted only to those collected by individuals 
who are willing to share the data? Should it include individ- 
uals who are open to negotiation for the use of their data, but 
who have no pledge to do so? In addition, there needs to be 
a mechanism for easy transfer of such data. 
3) A registry of study designs and data from the studies. 
Such a registry would include the study data, which then 
would be made available to others. This facilitates use of 
data with minima1 contact with the individuals collecting the 
data. This would have the benefits of easy and rapid use for 
a variety of purposes; the drawbacks have already been 
mentioned. 
4) A mechanism for publishing requests for appropriate 
data by the scientists who wish to engage in a modeling effort. 
Because the registry lists individuals who are looking for 
appropriate data sets and studies, extensive publicity might 
be required for it to succeed. 
5) A clearinghouse that enrolls both those looking for data 
and those having data. There would be appropriate key word 
systems; considerable thought would be put into the registry 
data collection forms. Of necessity, such forms would 
change quite regularly because of technologic advances. 
This type of registry would facilitate contact between appro- 
priate individuals. 
A registry of any type might consider using one of the 
international or national computer networks to allow contact 
by electronic mail. A registry might help develop a standard- 
ized protocol to facilitate electronic transfer of data. 
Other Important Issues for 
Collaborative Research 
A number of additional points need to be addressed when 
considering research collaboration. If there is a registry, is 
the enrollment to be voluntary or mandatory? If individuals 
place data sets in the registry, are they expected to collab- 
orate with any and all parties? Would there be adequate 
financial reimbursement for individuals sharing their data? 
Many important data sets would involve ongoing follow-up 
data collection. In addition, large data bases are occasionally 
corrected. How would additional data and corrected data get 
into the collaboratively used data base? Would there be a 
mechanism for making individuals using such data aware of 
such updates? 
How involved should those who collect the data be with 
those who analyze the data for a modeling effort? To 
motivate individuals who are collecting data to participate 
and to avoid analysis flaws might require one or more 
individuals from the data collection project to be involved in 
the analysis and in the writing of reports with the individuals 
who develop decision models. Who would have the author- 
ity to review and approve manuscripts? Would reports be 
restricted by needing the approval of those collecting the 
data? Would this be an inappropriate muffling of scientific 
integrity? Without controls, however, would there be misuse 
of one’s science? Can individuals contributing the data say 
when they will make certain parts of their data available, or 
have time points before which modelers could not use the 
data in the public domain? Having data analyzed for many 
purposes in many subsets of patients raises the specter of 
many inappropriate conclusions because of the “multiple 
comparison problem” (that is, chance findings). How can 
this be controlled? Would agreement to participate in a 
registry of studies imply anything about the availability of 
some data under freedom of information laws? 
Should the registry include data banks of financial infor- 
mation? For example, should third party carriers be encour- 
aged to participate? Should a registry be implemented in 
stages? To what degree and in what manner should foreign 
data bases and trials participate? Should some sets allow 
National Death Index linkage for cases through a “secure” 
third party? What are the trade-offs of detail and expense 
and ease of use? How can negative unpublished studies be 
identified and their registration encouraged? Such studies 
can be crucial to evaluating a therapy or procedure. 
A Position 
A design of the registry. We believe the most promising, 
practical registry would be the registry of descriptions of 
ongoing and completed studies and data bases without the 
actual data. The design of this registry should be determined 
by an expert committee of cardiologists, internists, thoracic 
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surgeons, radiologists, pathologists, epidemiologists and 
biostatisticians. This expert committee should have two 
responsibilities: 1) to establish the criteria for including or 
excluding a study from the registry; and 2) to establish the 
manner of recording the stored information about the study. 
The registry should include the information that is essen- 
tial for a possible collaborator to identify a potentially useful 
data base. It should not, however, include so much informa- 
tion that it would be impractical to maintain or would 
compromise the interests of the principal investigators. 
Examples of the type of information to be stored are as 
follows: the purpose of the study, the design of the study, the 
variables recorded, the references to published reports, 
restrictions on collaboration set by the principal investiga- 
tors and a method to obtain further information about the 
study. 
To encourage participation, the registry should be adver- 
tised by journals, the National Institutes of Health and the 
Federal Food and Drug Administration. In addition, funding 
agencies should inform the appropriate researchers about 
the registry at the time a study begins. Participation can also 
be encouraged by minimizing the inconvenience to research- 
ers contributing to the registry. The forms to submit data 
should be designed so that they require minimal effort for 
completion. Requests for collaboration should be screened 
to reduce the time spent by researchers responding to 
requests that are unlikely to be productive. One screening 
method would require that initial requests for collaboration 
be addressed to the registry. 
Funding. To perform the functions just outlined, a regis- 
try would require significant funding. This funding could be 
obtained from either public or private sources, but it is 
necessary to address the consequences of a given type of 
funding in terms of restrictions on the registry or the stability 
of the funding. A registry cannot be supported by funding 
from users. However, user fees may provide some additional 
revenue and may discourage casual use of the registry. 
Evaluations. Because of the trial nature of this proposal 
and the difficulty in foreseeing how it will work, there should 
be a plan for systematic evaluation that includes the follow- 
ing issues. If one can collect data on the number of studies 
that might appropriately be registered, how many of them 
actually registered? Were the health care modelers satisfied 
with the procedure? Were the individuals “possessing” the 
data satisfied? Finally, although it would involve many 
subjective elements, was the money spent on the project a 
reasonable expenditure or might it have been better used to 
support other research? 
Conclusions. The need and opportunities for society and 
individual investigators to develop a data registry for deci- 
sion modeling appear great. The best approach is unclear, 
and early efforts should be carefully evaluated. Given the 
complexities of modern science, the rapid changes in com- 
puter hardware and software and the realities of human 
motivation, substantial resources, dedication and ingenuity 
are required to develop a registry to facilitate much decision 
modeling. 
